Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

August-16-10

FDA Approves 5-Day Emergency Contraceptive

The Food and Drug Administration (FDA) has approved a new emergency contraceptive, Ella or ulipristal acetate, which is effective at preventing pregnancy up to five days after contraceptive failure or unprotected sexual intercourse. In June, a panel of FDA expert medical advisors unanimously agreed that it is safe and effective in preventing the release of an egg. The drug inhibits or delays ovulation by diminishing the effects of progesterone, according to theFDA release.

Ella will be available by prescription only, according to the Los Angeles Times.

According to the New York Times, Ella is more effective than Plan B, the "morning-after" pill available over the counter to women over the age of 17 in the United States. Plan B is only effective three days after contraceptive failure or unprotected sex. Side effects of Ella are similar to those of Plan B, including headache, nausea, abdominal pain, pain/discomfort during menstruation (dysmenorrhea), fatigue, and dizziness, according to WebMD Health News.

The drug, under the name EllaOne, is made by French company HRA Pharma. It is available with a prescription in Europe and is currently approved in 22 countries. Watson Pharmaceuticals Inc. will distribute Ella in the United States.

Anti-choice advocates argue that EllaOne is akin to mifepristone, which terminates existing pregnancies. According to Reuters, supporters of EllaOne agree that the drug is chemically similar to mifepristone, but one dose will not interfere with existing pregnancies. "There's just no evidence that it causes abortion," said Dr. Paul Fine, a Baylor College of Medicine professor and the medical director for Planned Parenthood in Houston and Southeast Texas.

Planned Parenthood has commended the FDA's decision. Planned Parenthood President Cecile Richards said, "Every woman deserves every option available to prevent an unplanned pregnancy, and there are many reasons why a woman may face the risk of unintended pregnancy, from failure or improper use of birth control to sexual assault," in a statement. "The FDA's approval of this new form of emergency contraception gives women one more option."

Media Resources: FDA Release; Feminist Newswire 6/16/10, 6/18/10; Los Angeles Times 8/13/10; New York Times 8/13/10; WebMD Health News 8/13/10; Planned Parenthood Press Release 8/13/10; Reuters 6/15/10


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

9/12/2014 Violence Against Women Act Turns 20 - Saturday will be the 20th Anniversary of the groundbreaking federal Violence Against Women Act (VAWA). Passed in 1994, VAWA was the first piece of federal legislation to specifically address domestic violence and sexual assault as crimes and to provide federal funding to improve local response to violence against women, including training and resources for law enforcement and judges. President Barack Obama on Tuesday issued a proclamation commemorating the VAWA anniversary. . . .
 
9/12/2014 Indiana Woman Charged With Feticide For Premature Delivery - An Indiana woman has been charged with feticide after she delivered prematurely and sought hospital treatment. Purvi Patel, 33, sought help at an emergency room for vaginal bleeding where it was discovered that she had delivered prematurely at home. . . .
 
9/11/2014 Missouri Legislators Pass 72-Hour Abortion Waiting Period Law - Missouri legislators voted late last night to triple the state's current 24-hour waiting period to 72 hours, with no exceptions for rape or incest. Governor Jay Nixon previously vetoed the bill in July, calling it "extreme and disrespectful." Missouri's House voted 117-44 to override the veto, and then the Senate used a procedural move to stop a Democratic filibuster of the bill and vote 23-7 to complete the veto override Wednesday. "The only purpose of a 72-hour waiting period is to attempt to punish, shame, and demean women who have arrived at a personal decision that politicians happen to disagree with," said the president and CEO of the Center for Reproductive Rights in a statement. . . .